WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that Daniel Junius, President and CEO, will present at the upcoming 34th Annual J. P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for 3:00 pm PT (6:00 pm ET) on January 12, 2016.
